17 March 2017
Oxford boldly goes into cannabinoid research
Oxford University has partnered Kingsley Capital Partners to conduct research into cannabis-based medication through a new company dubbed Oxford Cannabinoid Technologies.
Oxford University has joined forces with private equity and VC firm Kingsley Capital Partners for a research program into the use of cannabinoids to treat a range of acute and chronic conditions.
The strategic partnership will be supported by an initial £10m ($12.4m) investment provided by Kingsley. The research will be conducted…Read More.
10 November 2016
Oxford coats Lab282 in $16m investment
Oxford University today unveiled Lab282, a collaboration between the institution, its tech transfer office Oxford University Innovation (OUI), its commercialisation fund Oxford Sciences Innovation (OSI)…
9 November 2016
Calin calls for 240 Irish and Welsh SMEs
University College Dublin, National University of Ireland Galway, Tyndall National Institute, University College Cork, Bangor University, Cardiff University and Swansea University have partnered for…